HCC
Clinical trials for HCC explained in plain language.
Never miss a new study
Get alerted when new HCC trials appear
Sign up with your email to follow new studies for HCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI picks who gets immunotherapy after liver cancer surgery
Disease control Not yet recruitingThis study tests whether a computer model can help decide which liver cancer patients should receive immunotherapy (PD-1 inhibitors) after surgery to prevent the cancer from coming back. About 300 adults who had their liver cancer completely removed will be enrolled. The goal is …
Matched conditions: HCC
Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 17, 2026 04:27 UTC
-
New combo therapy aims to stop liver cancer from coming back
Disease control Not yet recruitingThis study tests whether giving a combination of an immunotherapy drug (sintilimab) and targeted radiation before surgery can help prevent liver cancer from returning. About 110 adults with resectable liver cancer will be randomly assigned to receive either the combination therap…
Matched conditions: HCC
Phase: PHASE2 • Sponsor: Lei ZHAO • Aim: Disease control
Last updated May 17, 2026 04:26 UTC
-
New 4-Drug cocktail aims to tame tough liver cancer
Disease control Not yet recruitingThis study tests a new combination of four treatments for people with liver cancer that cannot be removed by surgery and who also have high blood pressure in the liver (portal hypertension). The goal is to see if adding a blood pressure drug (carvedilol) to standard cancer therap…
Matched conditions: HCC
Phase: PHASE2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
Liver cancer trial hopes TACE boosts Immunotherapy's punch
Disease control Not yet recruitingThis study tests whether adding a targeted chemoembolization procedure (TACE) to standard immunotherapy can improve outcomes for people with advanced liver cancer that cannot be removed by surgery. About 90 participants will receive both treatments to see if the combination shrin…
Matched conditions: HCC
Phase: PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated May 17, 2026 04:13 UTC
-
New study aims to find best drug cocktail for tough liver cancers
Disease control Not yet recruitingThis study looks at two different treatment combinations for people with liver cancer that cannot be removed by surgery. One group gets a standard liver-directed therapy (TACE) plus two drugs, while the other gets a different liver-directed therapy (HAIC) plus the same two drugs.…
Matched conditions: HCC
Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New scan aims to spot liver cancer more clearly
Diagnosis Not yet recruitingThis early study will test a special imaging agent that targets liver cancer cells. About 6 people with suspected or confirmed liver cancer will receive a low-dose radioactive tracer and then have a SPECT-CT scan. The goal is to see how the tracer moves through the body and wheth…
Matched conditions: HCC
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated May 15, 2026 11:53 UTC
-
Blood test may predict liver cancer comeback
Knowledge-focused Not yet recruitingThis study looks at whether a simple blood test can detect leftover cancer cells after liver cancer surgery. It involves 276 adults with high-risk liver cancer. The goal is to see if the test can predict if the cancer will come back and who might benefit from extra immunotherapy …
Matched conditions: HCC
Phase: NA • Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC